Press releases
- PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
More ▼
Key statistics
As of last trade Bicycle Therapeutics PLC (50BA:DUS) traded at 18.50, 8.82% above its 52-week low of 17.00, set on Jul 04, 2024.
52-week range
Open | 17.70 |
---|---|
High | 18.50 |
Low | 17.70 |
Bid | 18.50 |
Offer | 18.70 |
Previous close | 18.40 |
Average volume | 242.86 |
---|---|
Shares outstanding | 49.71m |
Free float | 11.26m |
P/E (TTM) | -- |
Market cap | 1.00bn USD |
EPS (TTM) | -4.45 USD |
Data delayed at least 15 minutes, as of Jul 08 2024 11:31 BST.
More ▼